UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000060973
Receipt number R000069767
Scientific Title Thoracoabdominal Sensory Block Distribution Following SEDIC Block for Lateral Abdominal Surgery: A Prospective Observational Study
Date of disclosure of the study information 2026/03/18
Last modified on 2026/03/18 14:15:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Thoracoabdominal Sensory Block Distribution Following SEDIC Block for Lateral Abdominal Surgery: A Prospective Observational Study

Acronym

SEDIC-DIST Study

Scientific Title

Thoracoabdominal Sensory Block Distribution Following SEDIC Block for Lateral Abdominal Surgery: A Prospective Observational Study

Scientific Title:Acronym

SEDIC-DIST Study

Region

Japan


Condition

Condition

Robot-assisted partial nephrectomy, laparoscopic partial nephrectomy, laparoscopic adrenal surgery

Classification by specialty

Urology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We performed a SEDIC block in patients undergoing robot-assisted or laparoscopic partial nephrectomy and laparoscopic adrenal surgery, and prospectively evaluated the postoperative thoracoabdominal wall sensory block distribution using a pinprick test, particularly clarifying the extent of sensory block in the area of the lateral cutaneous branches.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Measure the effective range of the SEDIC block using a pin-prick test.

Key secondary outcomes

Cold sensation tests
QoR-15 (the Quality of Recovery-15) before surgery and on postoperative days 1 and 2
NRS (Numerical Rating Scale) values on postoperative days 1 and 2
usage of analgesics up to 24 hours postoperatively
the occurrence of adverse events will be recorded


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

Patients classified as 1 or 2 by the American Society of Anesthesiologists
Patients aged 20 years or older but under 85 years
Patients who provided written consent for this study

Key exclusion criteria

Patients undergoing emergency surgery applied for on the day of surgery
Patients who chronically use opioids
Patients allergic to local anesthetics
Patients who do not have the capacity to give consent
Patients with recognized coagulation abnormalities
Patients receiving antithrombotic therapy who do not have an adequate withdrawal period
Patients for whom sensory evaluation is difficult due to neurological disorders
BMI > 35
Weight < 50 kg
Surgery time > 6 hours
Patients deemed inappropriate as research subjects by the principal investigator

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Miki
Middle name
Last name Umehara

Organization

Nara Medical University

Division name

Department of Anesthesiology

Zip code

634-8522

Address

840 Shijo-cho, Kashihara City, Nara Prefecture

TEL

0744-22-3051

Email

k104465@naramed-u.ac.jp


Public contact

Name of contact person

1st name Miki
Middle name
Last name Umehara

Organization

Nara Medical University

Division name

Department of Anesthesiology

Zip code

634-8522

Address

840 Shijo-cho, Kashihara City, Nara Prefecture

TEL

0744-22-3051

Homepage URL


Email

k104465@naramed-u.ac.jp


Sponsor or person

Institute

Nara Medical University

Institute

Department

Personal name

Miki Umehara


Funding Source

Organization

Nara Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nara Medical University Ethics Committee

Address

840 Shijo-cho, Kashihara City, Nara Prefecture

Tel

0744-22-3051

Email

ino_rinri@naramed-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

奈良県立医科大学附属病院(奈良県)


Other administrative information

Date of disclosure of the study information

2026 Year 03 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 03 Month 17 Day

Date of IRB


Anticipated trial start date

2026 Year 04 Month 01 Day

Last follow-up date

2028 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

From the date of implementation approval until March 31, 2028, adult patients scheduled for robot-assisted or laparoscopic partial nephrectomy and laparoscopic adrenal surgery at this facility will be targeted.
The patient will be enrolled after receiving an explanation about the study before surgery and providing written consent.
This study is a prospective observational study.
After induction of general anesthesia, bilateral SEDIC blocks will be performed under ultrasound guidance.
Two hours after surgery, a pinprick test will be performed on the T4-L1 skin segments to determine the area of effect.
As secondary evaluation items, a cold sensation test in the same area, QoR-15 (the Quality of Recovery-15) on preoperative day and postoperative days 1 and 2, NRS (Numerical Rating Scale) values on postoperative days 1 and 2, use of analgesics up to 24 hours postoperatively, and the occurrence of adverse events will be recorded.


Management information

Registered date

2026 Year 03 Month 18 Day

Last modified on

2026 Year 03 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069767